Author:
Kuhn W.,Jänicke F.,Wilhelm O.,Schmitt M.,Graeff H.
Publisher
Springer Berlin Heidelberg
Reference15 articles.
1. Graeff H., Hafter R.: Clinical aspects of fibrinolysis. In: Bloom L., Thomas D.P. (eds): Haemostasis and Thrombosis. Edinburgh: Churchill Livingstone: 245–254,1987
2. Hafter R., Klaubert W., Gollwitzer R., von Hugo R., Graeff H.: Crosslinked fibrin derivates and fibronectin in ascitis fluid from patients with ovarian cancer compared to ascitic fluid in liver cirrhosis. Thromb. Res. 35: 53–64,1984
3. Röbl M., Jürgensmeyer K., Hafter R., Schröck R., Wilhelm O., Babic R., Graeff H.: Relation of fibrin and tumor-associated antigens to the spread of ovarian cancer. Fibrinolysis 1. 1: 143–148,1987
4. Wilhelm O., Hafter R., Coppenrath E., Pflanz M.A., Schmitt M., Babic R., Linke R., Gössner W., Graeff H.: Fibrin-fibronectin compounds in human ovarian tumor ascites and their possible relation to the tumor stroma. Cancer. Res. 48: 3507–3514, 1988
5. Wilhelm O., Hafter R., Henschen A., Schmitt M., Graeff H.: Role of plasmin in the degradation of the stroma-derived fibrin in human ovarian carcinoma. Blood 75: 1673–1678, 1990